MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT04916626 | COMPLETED | NA
284 participants

The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2021-05-06
Completion:
2026-04-15
Conditions
  • Schizophrenia
  • Schizotypal Disorder
  • Delusional Disorder
  • Acute and Transient Psychotic Disorder, Unspecified
  • Schizoaffective Disorder
  • Non-Organic Psychosis
  • Depression Severe
  • Substance Induced Psychoses
Interventions
  • BEHAVIORAL
No Results Yet
NCT04902872 | COMPLETED | PHASE1/PHASE2
69 participants

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2021-05-03
Completion:
2025-06-24
Conditions
  • Solid Tumor, Adult
  • Epithelial Ovarian Cancer
  • Small Cell Lung Carcinoma
  • Breast Cancer
  • Colorectal Cancer
  • Pancreas Cancer
  • Appendix Cancer
  • Non-small Cell Lung Cancer
  • Gastric Cancer
  • Esophagus Cancer
  • Urothelial Carcinoma
  • Sarcoma
Interventions
  • DRUG
No Results Yet
NCT04824248 | RECRUITING | NA
84 participants

Weight Reduction in CLBP

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2025-05-01
Completion:
2027-12-01
Conditions
  • Chronic Low-back Pain
  • Overweight or Obesity
Interventions
  • BEHAVIORAL
No Results Yet
NCT04673448 | ACTIVE_NOT_RECRUITING | PHASE1
18 participants

Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2021-10-18
Completion:
2025-12-31
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • BRCA-Associated Malignant Neoplasm
  • BRCA Hereditary Ovarian Carcinoma
  • Metastatic BRCA Hereditary Breast Carcinoma
  • Metastatic Breast Carcinoma
  • Metastatic Fallopian Tube Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Ovarian Carcinoma
  • Metastatic Pancreatic Carcinoma
  • Metastatic Primary Peritoneal Carcinoma
  • Prognostic Stage III Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Stage III Fallopian Tube Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
  • Stage III Primary Peritoneal Cancer AJCC v8
  • Stage IV Fallopian Tube Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Stage IV Primary Peritoneal Cancer AJCC v8
  • Unresectable Breast Carcinoma
  • Unresectable Fallopian Tube Carcinoma
  • Unresectable Malignant Solid Neoplasm
  • Unresectable Ovarian Carcinoma
  • Unresectable Pancreatic Carcinoma
  • Unresectable Primary Peritoneal Carcinoma
Interventions
  • BIOLOGICAL
  • DRUG
  • PROCEDURE
No Results Yet
NCT04667234 | NO_LONGER_AVAILABLE

Expanded Access of Sotorasib

Study Type:
EXPANDED_ACCESS
Last Updated:
2026-08-20
Conditions
  • Non Small-cell Lung Cancer
  • Locally Advanced Unresectable NSCLC
  • Locally Advanced Metastatic NSCLC
Interventions
  • DRUG
No Results Yet
NCT04665739 | RECRUITING | PHASE2
70 participants

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2023-02-03
Completion:
2027-07-01
Conditions
  • Advanced Lung Neuroendocrine Tumor
  • Functioning Lung Neuroendocrine Tumor
  • Locally Advanced Lung Neuroendocrine Neoplasm
  • Lung Neuroendocrine Neoplasm
  • Lung Neuroendocrine Tumor G1
  • Lung Neuroendocrine Tumor G2
  • Metastatic Lung Neuroendocrine Neoplasm
  • Metastatic Lung Neuroendocrine Tumor
  • Non-Functioning Lung Neuroendocrine Tumor
  • Recurrent Lung Neuroendocrine Neoplasm
  • Unresectable Lung Neuroendocrine Neoplasm
  • Unresectable Lung Neuroendocrine Tumor
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
NCT04582825 | ACTIVE_NOT_RECRUITING
5000 participants

Stroke-Card Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-20
Start Date:
2020-12-09
Completion:
2027-03-31
Conditions
  • Ischemic Stroke
  • Transient Ischemic Attack
Interventions
  • OTHER
No Results Yet
NCT04572451 | ACTIVE_NOT_RECRUITING | PHASE1
50 participants

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2021-11-29
Completion:
2026-10-07
Conditions
  • Melanoma
  • Unresectable Solid Tumors
  • Neoplasms
  • Neoplasms by Histologic Type
  • Neoplasms by Site
  • Antineoplastic Agents, Immunological
  • Antineoplastic Agents
  • Immune Checkpoint Inhibitors
  • Molecular Mechanisms of Pharmacological Action
  • Nivolumab
Interventions
  • DRUG
  • RADIATION
No Results Yet
NCT04497844 | ACTIVE_NOT_RECRUITING | PHASE3
696 participants

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2020-09-23
Completion:
2025-01-07
Conditions
  • Metastatic Castration-sensitive Prostate Cancer
Interventions
  • COMBINATION_PRODUCT
  • DRUG
Results Available
NCT04457622 | COMPLETED | NA
264 participants

Language and Brain Rhythms

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2021-02-18
Completion:
2026-03-16
Conditions
  • Healthy Volunteers
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page